Insider · CIK 0001464907

Ramos Eleanor

Reports to the SEC for 3 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001464907

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-27	Provention Bio, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−70K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−460K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−400K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−138K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−140K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−145K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−210K sh	—	—	0
2023-01-10	Provention Bio, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+210K sh	—	—	210,000
2022-12-08	Provention Bio, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+20.7K sh	—	—	75,763
2022-11-22	Provention Bio, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	400,000
2022-01-18	Provention Bio, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+145K sh	—	—	145,000
2021-12-03	Provention Bio, Inc.P Purchase	Chief Medical Officer	PPurchase	+5,201 sh	$6.49	+$33.8K	70,000
2021-05-12	Provention Bio, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+140K sh	—	—	139,500
2020-09-02	Provention Bio, Inc.P Purchase	Chief Medical Officer	PPurchase	+299 sh	$12.06	+$3,605.94	64,799
2020-08-20	Provention Bio, Inc.P Purchase	Chief Medical Officer	PPurchase	+2,500 sh	$13.23	+$33.1K	64,500
2020-07-15	Provention Bio, Inc.Option (right to buy)A Award	Chief Medical Officer	AAward	+138K sh	—	—	137,750
2019-12-26	Provention Bio, Inc.P Purchase	Chief Medical Officer	PPurchase	+2,000 sh	$14.34	+$28.7K	62,000
2019-06-24	Provention Bio, Inc.Option (right to buy)A Award	Chief Medical Officer	AAward	+400K sh	—	—	400,000
2018-07-19	Provention Bio, Inc.P Purchase	Chief Medical Officer	PPurchase	+60K sh	$4.00	+$240K	60,000
2016-09-29	Global Blood Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+9,286 sh	—	—	9,286
2016-03-10	Global Blood Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+9,286 sh	—	—	9,286
2016-02-01	Global Blood Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+1,470 sh	$16.09	+$23.7K	12,470
2015-12-22	Global Blood Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,000 sh	$30.28	+$30.3K	11,000
2015-12-22	Global Blood Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,000 sh	$30.28	+$30.3K	11,000
2015-08-17	Global Blood Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$20.00	+$200K	10,000
2015-08-17	Global Blood Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+1,000 sh	$20.00	+$20K	1,000
2015-08-17	Global Blood Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$20.00	+$200K	10,000
2010-10-08	ZYMOGENETICS INCU Disposition from Tender	Sr. VP, Chief Medical Officer	UDisposition from Tender	−3,599 sh	$9.75	−$35.1K	2,500
2010-02-24	ZYMOGENETICS INCS Sale	Sr. VP, Chief Medical Officer	SSale	−662 sh	$5.66	−$3,746.92	6,099
2010-01-29	ZYMOGENETICS INCStock Option (Right to Buy)A Award	Sr. VP, Chief Medical Officer	AAward	+48.2K sh	—	—	48,150
2009-12-16	ZYMOGENETICS INCStock Option (Right to Buy)D Disposition to Issuer	Sr. VP, Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2009-12-16	ZYMOGENETICS INCStock Option (Right to Buy)A Award	Sr. VP, Chief Medical Officer	AAward	+28.6K sh	—	—	28,570

Recent filings

Accepted (ET)
Apr 274
Ramos Eleanor0001493152-23-013906
SEC(opens sec.gov)
Jan 114
Ramos Eleanor0001493152-23-001214
SEC(opens sec.gov)
Dec 94
Ramos Eleanor0001493152-22-035098
SEC(opens sec.gov)
Nov 234
Ramos Eleanor0001493152-22-033638
SEC(opens sec.gov)
Jan 204
Ramos Eleanor0001493152-22-001754
SEC(opens sec.gov)
Dec 64
Ramos Eleanor0001493152-21-030639
SEC(opens sec.gov)
May 144
Ramos Eleanor0001493152-21-011592
SEC(opens sec.gov)
Sep 24
Ramos Eleanor0001493152-20-017180
SEC(opens sec.gov)
Aug 204
Ramos Eleanor0001493152-20-016458
SEC(opens sec.gov)
Jul 164
Ramos Eleanor0001493152-20-013478
SEC(opens sec.gov)
Dec 264
Ramos Eleanor0001493152-19-019733
SEC(opens sec.gov)
Jun 254
Ramos Eleanor0001493152-19-009706
SEC(opens sec.gov)
Jul 194
Ramos Eleanor0001493152-18-010232
SEC(opens sec.gov)
Oct 34
Global Blood Therapeutics, Inc.0000899243-16-030588
SEC(opens sec.gov)

Companies

Address

C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE EAST

SEATTLE, WA, 98102